Jane Jin’s Post

CorePath Laboratories Internalizes Genomic Testing Cooperative’s State-Of-The-Art Next-Generation Sequencing (NGS) Testing for Solid Tumors and Hematologic Neoplasms “NGS is not only important for selecting the proper therapy for a specific patient but has become essential for complementing other conventional diagnostic procedures in providing accurate diagnosis and classification of various tumors, especially when RNA is combined with DNA,” stated Aamir Ehsan, MD, CEO and Founder of CorePath. “We are delighted to be working with the GTC team on this and have found their testing approach to be comprehensive, clinically focused, and cost-effective,” added Dr. Ehsan. Read the full press release featuring Genomic Testing Cooperative and Dr. Maher Albitar ➡️ https://lnkd.in/dateEH-4 Curtis Loos, Connie Cornish #GTC #genomics #NGS #nextgenerationsequencing #liquidbiopsy #molecular #moleculartesting #collaboration #patientcare #medicine #healthcare #diagnostics #cancerdiagnostics #genetictesting #CaringforLives

The DeciBio reports team has been busy, adding our Oncology Liquid Biopsy report to the list of reports published this year! Up next is the second edition of our Digital & Computational Pathology report, which is expected to be published in Q3 and will feature a new section on the use of image analysis and AI tools. Check out our website to purchase or find more information about any of these reports: https://lnkd.in/gpYWAsiT Fill out this form to add yourself to the notification list for any of our upcoming reports: https://lnkd.in/g4gTx6xN Reach out to Andrew Aijian or Rebecca Burnham, PhD if you're interested in subscribing to our entire report / content library. We’d also love to hear of any ideas for report topics that you’d like to see us publish on in the future - let us know in the comments! #precisionmedicine #spatialbiology #liquidbiopsy #biomarkers #diagnostics #digitalpathology #singlecell #genomics #proteomics #cellomics #oncology #celltherapy #research #pharma #drugdiscovery #clinicalresearch #marketresearch

Mark your calendars for September 10th! Velsera's webinar will explore the complexities of oncology variant analysis and present CGW Plus, our reimagined solution for clinical genomics. Learn how to automate and accelerate the analysis of genomic alterations. Register now! https://lnkd.in/g5guzA8C #EraofVelsera #Genomics #Webinar #ClinicalGenomics #PrecisionMedicine

Mark your calendars for September 10th! Velsera's webinar will explore the complexities of oncology variant analysis and present CGW Plus, our reimagined solution for clinical genomics. Learn how to automate and accelerate the analysis of genomic alterations. Register now! https://lnkd.in/e7YrMfJg #EraofVelsera #Genomics #Webinar #ClinicalGenomics #PrecisionMedicine

UGenome provides bioinformatics services in medical assessment for breast cancer treatment Background Fibrotic-like matrix stiffness pro- motes distinct metastatic phenotypes in cancer cells, which are preserved after transition to softer microen- vironments, such as bone marrow. Using differential gene expression analysis a score of mechanical conditioning (MeCo) associated with bone metastasis in patients with breast cancer. Watson, A. W., Grant, et al. (2021). Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioning. Cell reports. UGenome's Service Client had access to RNA-seq data from breast cancer patients before treatment with Nintenab* UGenome pre-processed and aligned the RNA-seq data to a reference genome. UGenome converted the aligned RNA-seq data to transcripts per million and calculated a MeCo score for each patient. *Nintedanib is used to treat idiopathic pulmonary fibrosis #ugenome, #ugenomeai, #ugenomebiotech, #bioinformatics, #biotech, #genetics, #science, #dna, #research, #genomics, #medicine, #immunology, #drugdiscovery, #datascience, #lifesciences, #biostatistics, #health, #pharma, #genomeannotation, #pharmacogenomics, #pharmacogenetics, #genomicmedicine, #sequencing, #dataanalysis, #machinelearning, #precisionmedicine, #metagenomics,

The European Society for Medical Oncology congress is next week! Join us to learn how we are putting a new spin on whole genome sequencing! Want to meet up and learn more about the UG 100™? Sign up for a meeting here: 👉 https://lnkd.in/gz7BnUfs #ESMO24 #NGS #WGS #Sequencing #UltimaGenomics #UG100

Few diseases are as complex as hematological cancers. The number of alternative treatments considered for patients at different points throughout their care is more varied and individualized than what is seen in diagnosis and management of solid tumors. Hematological malignancies require surveillance of patients over multiple time periods with numerous clinical and diagnostic measures to assess sustained response to treatment or relapse. Learn more about how NeoGenomics worked with ConcertAI to establish a robust and definitive (RWE) hematology solution.  

The Emergence of Multi-modal Real-world data: The power of Clinico-Genomic data versus traditional RWD Sources is a new #whitepaper that explores crucial and emerging topics, such as: • Why biomarker and genomic data matters for life science • How these data sources unlock what’s been missing from traditional RWD sources • How these newly created longitudinal data sets support drug development from discovery to trial to post-market • Why longitudinal data matters for developing targeted treatments for rare or complex conditions such as multiple myeloma • How tokenization allows for better integration of disparate data sources and meets the scrutiny of peer review and regulatory approval Visit us online to read this whitepaper: https://lnkd.in/gRYNims7 #NeoGenomics #RWD #Oncology

The market is in a medium growth stage, accelerating due to innovative technologies for early detection and treatment, such as liquid biopsy tests, genomic profiling, and advanced imaging. AI has also revolutionized the liver cancer diagnostics market. Visit @ https://lnkd.in/gktzvta8 #GVR #livercancer #Diagnostics #cancerdiagnosis #medicalimaging #livercancertreatment #precisionmedicine #genomics #proteomics #cancerresearch #biotechnology #healthcareinnovation 

✨ Published in Molecular #Cancer: The article established a culture method for human MPM #organoids using tumor tissue from MPM patients. #Histopathological analysis and whole genome sequencing (WGS) were employed to determine the ability of #MPMOs to replicate the original tumor's genetic and histological characteristics. The subcutaneous and orthotopic #xenograft #models were employed to assess the feasibility of establishing an in vivo model of MPM. MPMOs were also used to conduct drug screening and compare the results with retrospective analysis of patients after treatment, in order to evaluate the potential of MPMOs in predicting the effectiveness of drugs in MPM patients. 👉 Related Product Recommendation: Hyaluronidase Hyaluronidase (Hyaluronate 4-glycanohydrolase; #Hyaluronoglucosaminidase) is a naturally occurring #enzyme that depolymerizes hyaluronic acid by cleavage of glycosidic bonds. https://lnkd.in/gjxkkv82 👉 For more detailed information: https://lnkd.in/d8TMmcVb